نتایج جستجو برای: itd mutation

تعداد نتایج: 292736  

Journal: :Blood 2001
M Levis K F Tse B D Smith E Garrett D Small

Internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 have been found in 20% to 30% of patients with acute myeloid leukemia (AML). These mutations constitutively activate the receptor and appear to be associated with a poor prognosis. Recent evidence that this constitutive activation is leukemogenic renders this receptor a potential target for specific therapy. In thi...

2013
Rafael T Neto Didir Q Cagnini Renée L Amorim

Background The c-KIT proto-oncogene encodes the receptor tyrosine kinase KIT, which has been shown to play important roles in the cellular maturation, survival, proliferation, and migration of several cell types including mast cells. Mast cell tumors (MCTs) are the most common cutaneous tumor in the dog. MCTs exhibit wide variation in biological behavior. KIT mutations and aberrant KIT expressi...

Journal: :Blood 2007
Martin Bornhäuser Thomas Illmer Markus Schaich Silke Soucek Gerhard Ehninger Christian Thiede

In the July 1, 2006, issue of Blood, Meshinchi et al1 comment on the role of stem-cell transplantation (SCT) in FLT3/ITD-positive acute myeloid leukemia (AML). In their interpretation of data previously presented by Gale et al,2 they conclude that the occurrence of a FLT3/ITD may not be regarded as a negative prognostic factor in patients undergoing allogeneic SCT. The dispute between both auth...

Journal: :Blood 2009
Friederike Schneider Eva Hoster Michael Unterhalt Stephanie Schneider Annika Dufour Tobias Benthaus Gudrun Mellert Evelin Zellmeier Stefan K Bohlander Michaela Feuring-Buske Christian Buske Jan Braess Susanne Fritsch Achim Heinecke Maria C Sauerland Wolfgang E Berdel Thomas Buechner Bernhard J Woermann Wolfgang Hiddemann Karsten Spiekermann

Mutations in the NPM1 gene represent the most frequent genetic alterations in patients with acute myeloid leukemia (AML) and are associated with a favorable outcome. In 690 normal karyotype (NK) AML patients the complete remission rates (CRs) and the percentage of patients with adequate in vivo blast cell reduction 1 week after the end of the first induction cycle were significantly higher in N...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2015
Smith Giri Shadi Hamdeh Vijaya Raj Bhatt James K Schwarz

Old age (≤65 years), relapsed or refractory disease, and the presence of FMS-like receptor tyrosine kinase-3 (FLT3) internal tandem duplication (ITD) mutation are poor prognostic factors in acute myeloid leukemia (AML). FLT3 inhibitors such as sorafenib have been shown to have a potential role in treating relapsed or refractory AML with FLT3 mutations. In the present report, the use of sorafeni...

2015
Sang Hyuk Park Jae-Cheol Choi Shine Young Kim Jongyoun Yi Seung Hwan Oh In-Suk Kim Hyung-Hoi Kim Chulhun Ludgerus Chang Eun Yup Lee Moo-Kon Song Ho-Jin Shin Joo Seop Chung

BACKGROUND DNA methyltransferase 3A (DNMT3A) mutation was recently introduced as a prognostic indicator in normal karyotype (NK) AML and we evaluated the incidence and prognostic impact of DNMT3A mutations in Korean NK AML patients. METHODS Total 67 NK AML patients diagnosed during the recent 10 years were enrolled. DNMT3A mutations were analyzed by direct sequencing and categorized into nons...

2016

Background: Iodide transport defect (ITD) is a dyshormonogenetic congenital hypothyroidism caused by sodium/iodide symporter (NIS) gene mutations. In the lactating mammary gland, iodide is concentrated by NIS, and iodine for thyroid hormone synthesis is thereby supplied to the infant in the breast milk. Case Description: A 34-year-old Japanese woman was diagnosed with ITD caused by a homozygous...

Journal: :Blood 2004
Patrick Brown Soheil Meshinchi Mark Levis Todd A Alonzo Robert Gerbing Beverly Lange Robert Arceci Donald Small

Pediatric acute myelogenous leukemia (AML) has a poor prognosis, and novel therapies are needed. The FLT3 tyrosine kinase represents a promising target in pediatric AML. FLT3 is constitutively activated either by an internal tandem duplication (ITD) or by a point mutation (PM) in 17% to 24% of pediatric AML cases. Autocrine stimulation of wild-type (WT) FLT3 by coexpressed FLT3 ligand (FL) occu...

Journal: :Molecular cancer research : MCR 2010
Rehan Ahmad Suiyang Liu Ellen Weisberg Erik Nelson Ilene Galinsky Colin Meyer Donald Kufe Surender Kharbanda Richard Stone

Mutations of the FLT3 receptor tyrosine kinase consisting of internal tandem duplications (ITD) have been detected in blasts from 20% to 30% of patients with acute myeloid leukemia (AML) and are associated with a poor prognosis. FLT3/ITD results in constitutive autophosphorylation of the receptor and factor-independent survival in leukemia cell lines. The C-28 methyl ester of the oleane triterp...

Journal: :Haematologica 2003
Ti Ling Chang Manuel Salto-Tellez Yan Koon Kueh Evelyn S C Koay

Introduction Flt-3 mutations, which include the internal tandem duplications (ITD) and missense mutations at the D835 (aspartic acid) codon,2 are arguably the most common somatic mutations in acute myeloid leukemia (AML). As relapse remains the principal cause of treatment failure for the majority of AML patients, identification of patients with a high risk of relapse would be useful for the in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید